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326Objectives: To determine the incidence of surgical site infections (SSIs) in congenital heart surgery (CHS)
patients undergoing delayed sternal closure (DSC) and to evaluate risk factors for SSI.
Methods: A nested case–control study was performed within a cohort of CHS patients undergoing DSC at our
institution between 2005 and 2009. Cases met 2008 Centers for Disease Control and Prevention criteria for SSI;
control subjects were matched based on year of surgery. Uni- and multivariate logistic regressions were per-
formed to identify SSI risk factors.
Results: Of 375 patients who underwent DSC, 43 (11%) developed an SSI. The analysis included 172 patients
(43 cases, 129 controls); 118 (69%) were neonates, 80 (47%) had undergone Norwood procedure, and 150
(87%) had DSC initiated in the operating room. Case and control subjects were similar based on pre- and intra-
operative characteristics. Duration of mechanical ventilation, intensive care unit and hospital length of stay, and
mortality were significantly greater in patients with an SSI. Multiple periods of DSC, longer duration of DSC,
greater dependence on parenteral nutrition, and extracorporeal membrane oxygenation were significantly asso-
ciated with SSI in univariate analyses. Multivariate analysis demonstrated that multiple periods of DSC (ad-
justed odds ratio, 5.9; 95% confidence interval, 1.7-20.1) and extracorporeal membrane oxygenation
(adjusted odds ratio, 2.9; 95% confidence interval, 1.1-7.6) remained independent risk factors for SSI.
Conclusions: For CHS patients undergoing DSC, extracorporeal membrane oxygenation and multiple periods
of DSC are independent risk factors for SSI. New strategies for prevention and prophylaxis of SSI may be
indicated for these high-risk patients who have worse outcomes and greater health care resource utilization.
(J Thorac Cardiovasc Surg 2013;146:326-33)Earn CME credits at
http://cme.ctsnetjournals.org
Delayed sternal closure (DSC) is frequently required in the
care of pediatric patients who have undergone cardiac
surgery to minimize postoperative respiratory and hemody-
namic instability.1-3 Although necessary for the treatment of
unstable patients, DSC may expose patients to an increased
risk of hospital-acquired infections, including bloodstream4
and surgical site infections (SSIs).5-7 SSI remains a rare
complication for patients undergoing congenital heart
surgery (CHS), but when present it is associated with
significant morbidity, mortality, and health care costs.8,9
Recent studies demonstrate that the incidence ofSSI and as-
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The Journal of Thoracic and Cardiovascular Surghighly variable.6,7,10 Vulnerable patient populations likely to
be at high risk of SSI, such as those requiring extracorporeal
membrane oxygenation (ECMO) support, have been
excluded from previous studies.5,6 Furthermore the potential
causative factors for SSI in this patient population have been
as yet incompletely explored or characterized.6,7 A clear
understanding of outcomes and risk factors is essential
because they may affect clinical decision making for cardiac
surgeons and intensivists caring for these patients.
The purpose of this study was to determine the incidence
and risk factors for SSI in CHS patients undergoing DSC.
Our analysis of risk factors focused on processes of care
in an intensive care unit, because these are potentially mod-
ifiable. Examples of modifiable processes of care include
use of postoperative stress steroids and dependency on par-
enteral nutrition. We hypothesized that CHS patients under-
going DSC would have a higher incidence of SSI compared
with non-DSC patients, and that duration to chest closure
would be an independent risk factor for SSI.METHODS
Study Cohort
We studied a cohort of pediatric patients (aged<18 years) from our
institution who underwent DSC after cardiac surgery between January 1,
2005, and December 31, 2009. Study approval with waiver of written in-
formed consent was obtained from our institutional review board. A total
of 375 patients who underwent DSC were identified. All patientsery c August 2013
Abbreviations and Acronyms
CDC ¼ Centers for Disease Control and
Prevention
CHS ¼ congenital heart surgery
CICU ¼ cardiac intensive care unit
DSC ¼ delayed sternal closure
ECMO ¼ extracorporeal membrane oxygenation
SSI ¼ surgical site infection
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Dundergoing DSC, including those who required ECMO or emergency ster-
notomy for hemodynamic instability in our cardiac intensive care unit
(CICU), were included. Elective DSC defines any patient for which a deci-
sion was made by an attending surgeon to leave the chest open in the oper-
ating room. Because this decision can be made a priori or due to
intraoperative hemodynamic instability, the location the chest was opened
was determined rather than classifying DSC as elective or emergent. At our
center, we perform DSC for all patients who undergo stage 1 palliation for
single-ventricle disease regardless of intraoperative status. Subjects who
survived<48 hours after surgery were excluded from the analysis.
Study Design and Primary Outcome Definition
A nested case-control study was conducted within the DSC cohort com-
paring subjects with SSI to those without SSI. Cases of SSI were defined
and classified as superficial incisional, deep incisional, or organ/space us-
ing published Centers for Disease Control and Prevention (CDC) criteria.11
Mediastinitis and endocarditis are categorized as organ/space SSI accord-
ing to these definitions. Complete CDC criteria for SSI are displayed in
Appendix 1. Consistent with the criteria, the follow-up period during which
a SSI could occur was up to 30 days after surgery for patients without
surgical implants and 1 year for patients with implants. Control subjects
were matched to case subjects in a 3:1 ratio based on year of surgery.
Surgical Technique
Our standard technique for patients with DSC is closure with a silicone
elastomer membrane sutured to the skin edges with a monofilament suture.
No antibiotic ointment is placed on the skin edges. Polyurethane, iodine-
impregnated, occlusive film is then applied over the membrane. This dress-
ing remains in place until sternal closure or further mediastinal procedures
are indicated.
The decision to close a sternum is at the discretion of the attending car-
diac intensivist and surgeon. Typically, the sternum is closed when the pa-
tient is hemodynamically stable with an established diuresis. Sternal
closure occurs under sterile conditions in either a CICU or operating
room. A deep tissue sample is taken from the mediastinum for culture
and sensitivity at the time of sternal closure in all cases. The mediastinum
is irrigated with warm vancomycin irrigation. Chest tubes are cleared of all
clots and repositioned. All intracardiac catheters are removed and only re-
placed if clinically indicated. Following adequate hemostasis, the sternal
edges are reapproximated with either interrupted stainless steel wires or
braided absorbable sutures. The soft tissues and skin are closed using
braided absorbable sutures in a running fashion. Sedation, analgesia, and
neuromuscular blockade are provided during sternal closure using ket-
amine (1 mg/kg/dose), midazolam (0.1 mg/kg/dose), fentanyl (5 mg/kg/
dose), and vecuronium (0.1 mg/kg/dose). There were no changes to the
standard techniques for DSC or sternal closure during the study period.
Antibiotic Prophylaxis and Therapy
Patients undergoing DSC receive intravenous vancomycin and gentami-
cin for the duration of open chest and continuing until 48 hours after sternal
closure. Vancomycin is initially dosed at 10 mg/kg/dose every 12 hours and
adjusted to achieve a trough level of 5 to 10 mg/dL. Gentamicin is initiallyThe Journal of Thoracic and Cadosed at 2.5 mg/kg/dose every 12 hours and was adjusted to achieve
a trough level<2 mg/dL. Cefotaxime (50 mg/kg/dose every 12 hours)
was substituted for gentamicin in patients who developed renal insuffi-
ciency. After discontinuation of this regimen, prophylactic antibiotic
coverage for indwelling mediastinal and pleural chest tubes (intravenous
cefazolin) is initiated. Prophylaxis is continued until all chest tubes are
removed. Antibiotic coverage is broadened based on clinical judgment in
patients who develop fever or other clinical evidence of infection. Our stan-
dard practice is to treat all patients who have a positive mediastinal culture
with a 6-week antibiotic course.
Data Collection
All CHS patients who underwent DSC during the study period were
identified using our institution’s surgical database and a database search
of the medical records in the clinical data repository. Two search methods
were used to minimize selection error and to ensure accurate identification
of all cases. We reviewed the records of all patients identified by both
search tools using the Electronic Medical Record Search Engine. This
search tool is an internally developed computer application designed to per-
form detailed searches of the medical documents in our electronic medical
record and has been shown to improve efficiency and accuracy of electronic
medical record review.12,13 This methodology allowed us to resolve the
discrepancies and accurately identify the number of patients who
underwent DSC during the study period.
Infection control data at our institution are obtained by a dedicated nurse
specialist team that independently reviews and classifies all cases, includ-
ing those requiring readmission for management of SSI remote from the
initial surgical procedure. Use of a nurse specialist team has been shown
to improve the accuracy of reported rates of hospital-acquired infections14
so we used our institution’s infection control data to identify subjects with
SSI during the study period. We also searched our institutional surgical
database to try and identify any additional cases for consideration, and
no additional cases were identified.
After all case and control subjects were identified, the primary author re-
viewed the medical record for all preoperative, intraoperative, and postoper-
ative variables. When possible, these data were exported from the
institutional surgical database. Review for each patient was completed up
to the date of maximum possible SSI surveillance period defined by the
CDC criteria11 or until no further recordswere available. Surgical procedures
were grouped into stage I palliation for single ventricle, other single-ventricle
procedures, aortic arch reconstruction, and other 2- ventricle procedures.
Aortic arch reconstructionswere separated fromother 2-ventricle procedures
because these cases are performedusing hypothermic circulatory arrest. Total
duration of DSC was a cumulative total of the number of days the sternum
remained open during the hospital admission, including all periods of
DSC. Mediastinal procedures included ECMO cannulation/decannulation,
mediastinal exploration, and epicardial pacemaker lead placement.
Statistical Analysis
Data are presented as frequencies with percentage for categorical vari-
ables and median with interquartile range for continuous variables. The
incidence of SSI was reported as the cumulative incidence proportion.
The comparison of the incidences of SSI between patients with DSC versus
all CHS patients at our institution was made using c2 test. Demographics,
intraoperative, postoperative, and clinical outcome variables were com-
pared between cases and controls using c2 test or Fisher exact test, as
appropriate, for nominal variables, Mantel-Haenszel test for ordinal vari-
ables, and Wilcoxon rank sum test for continuous variables. Continuous
variables in the intraoperative and postoperative data were also evaluated
categorically using the median, with the exception of the duration of initial
DSC, for which we used an optimal cutoff obtained from a receiver oper-
ating characteristic curve. Variables found to be significantly associated
with SSI in the univariate analyses (P<.10) were investigated further by
building multivariate logistic regression models to determine independentrdiovascular Surgery c Volume 146, Number 2 327
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Drelations of risk factors with SSI. Model selection from multivariate logis-
tic regressions was conducted using backward elimination method and
improvements in the model fit were evaluated by the model c2 statistics.
Results of the logistic regression are presented as odds ratio (OR) with
95% confidence intervals (CIs). All analyses were performed using SAS
version 9.3 (SAS Institute Inc, Cary, NC).
RESULTS
Our cohort included 375patientswhounderwentDSCdur-
ing the study period. Of these, 43 (11%) patients met CDC
criteria for SSI (12 superficial incisional, 3 deep incisional,
and 28 organ/space). There were 27 cases of mediastinitis
and 1 case of endocarditis within the group of patients with
organ/space SSI. The incidence of SSIwithin theDSCcohort
was 11% (43 out of 375) and the incidence of organ/deep
space SSI was 7.5% (28 out of 375). The incidence of SSI
amongstCHSpatientswhodid not undergoDSCat our center
during the study period was 1.4% (41 out of 2891), signifi-
cantly lower than the DSC cohort (P<.0001 from c2 test).
A total of 172 patients (43 cases and 129 controls) were
included in the analysis. Demographic and intraoperative
data are shown in Table 1. There were no significant differ-
ences between case subjects and control subjects based on
race, age at surgery, or sex. Intraoperative factors were sim-
ilar in both groups, including surgical complexity and car-
diopulmonary bypass times. A small but similar
percentage of case and control subjects required emergent
sternotomy in the CICU (14% vs 12%; P ¼ .79). Stage I
single-ventricle palliation represented the most frequently
performed surgical procedure in both groups. The distribu-
tion of the primary surgical procedures performed on
patients in the analysis is displayed in Appendix 2.
Multiple postoperative factors differed significantly be-
tween cases and controls on univariate analysis (Table 2).
A majority (92%) of all patients requiring DSC had only
a single period of DSC. The median total duration of DSC
for cases was 9 (interquartile range [IQR], 3-14) and was
significantly increased compared with controls (median,
4; IQR, 3-6; P ¼ .0003). The duration of initial DSC of 5
days obtained from receiver operating characteristic curve
had relatively high negative predictive value (83%) but lim-
ited positive predictive value (34%). Cases more frequently
required multiple periods of DSC and ECMO during the
hospital stay, and had greater dependence on parental nutri-
tion. Amongst patients with SSI, the median intensive care
unit length of stay was 29 days (IQR, 13-48) and the rate of
intensive care unit mortality was 42%, both were signifi-
cantly increased compared with control subjects (P<.004
and P<.0001, respectively) (Table 3).
Candidate predictors that differed between case subjects
and control subjects (P<.10) in univariate analyses were in-
cluded in the multivariate model; total periods of DSC, du-
ration of initial DSC, total number of additional
mediastinal procedures, duration of mediastinal chest tubes,
prolonged use of parenteral nutrition, use of stress doses of328 The Journal of Thoracic and Cardiovascular Surghydrocortisone, and ECMO. The total number of additional
mediastinal procedures and the duration ofmediastinal chest
tubes were highly correlated with use of ECMO (c2, 66.4
and 43.1, respectively; both P<.0001), and thus excluded
from themultivariate model to avoidmulticollinearity. Mul-
tivariate logistic regression analysis using backward elimi-
nation method showed that >1 period of DSC was
significantly associatedwith increased risk of SSIwhen con-
trolling for other variables (OR, 5.9; 95% CI, 1.7-20.1),
whereas the duration of initial DSC was no longer statisti-
cally significant (OR, 1.7; 95% CI, 0.7-3.8). Use of
ECMO also remained an independent risk factor for SSI in
themultivariate model (OR, 2.9; 95%CI, 1.1-7.6) (Table 4).
DISCUSSION
DSC is a necessary postoperative technique used with
many CHS patients. It is imperative for surgeons and inten-
sivists to understand the associated risks of this procedure
and the extent to which specific care processes may posi-
tively or negativelymodify this risk. Our retrospective study
demonstrates that patients undergoing DSC are at signifi-
cantly increased risk of SSI compared with other CHS
patients. Multivariate analysis identified multiple periods
of DSC and the use of ECMO as independent risk factors
for SSI in this patient population. We did not identify any
specific processes of care that were independently associ-
ated with risk of SSI in patients undergoing DSC.
Our incidences of SSI (11%) and organ/deep SSI (7.5%)
were both higher than the previously published rates by
Tabbutt and colleagues6 (6.7% and 3.9%, respectively).
One explanation for these differences is the inclusion of
higher-risk patients in our analysis; in the study by Tabbutt
and colleagues6 patients requiring multiple episodes of
DSC or ECMO were excluded, and only 29% of patients
had undergone stage I single-ventricle palliation compared
with 47% in our cohort.
Two recent retrospective studies also described lower
rates of SSI in pediatric patients requiring DSC. Shin and
colleagues7 reported a rate of SSI of 3.3% based on a single
institutional review, and Johnson and colleagues5 reported
a rate of SSI of 6.4% in centers with high use of DSC in
stage 1 palliation procedures based on multicenter Society
of Thoracic Surgeons database review. Neither of these
studies adhered strictly to the CDC criteria for SSI and
infection data were not identified by a dedicated infection
control nurse specialist team. Methodologic differences
may have led to an underestimation of the incidence of
SSI in these other cohorts. This highlights the importance
of using dedicated infection control data for the retrospec-
tive analysis of SSIs and other nosocomial infections.
At our center we perform DSC for all patients who un-
dergo stage 1 palliation for single-ventricle heart disease re-
gardless of hemodynamic status in the operating room. For
all other patients who have DSC in the OR, the decision is atery c August 2013
TABLE 1. Demographic and intraoperative characteristics
Patient characteristic All (n ¼ 172)
Surgical site infection
P value*Yes (n ¼ 43) No (n ¼ 129)
Male 94 (54.7) 20 (46.5) 74 (57.4) .22
Race
White 114 (66.3) 28 (65.1) 86 (66.7) .26
African American 16 (9.3) 7 (16.3) 9 (7.0)
Other/unknown 28 (16.3) 7 (16.3) 21 (16.3)
Missing 14 (8.1) 1 (2.3) 13 (10.1)
Age at surgery (d) 9 (6-105) 12 (6-189) 9 (6-70) .34
30 54 (31.4) 15 (34.9) 39 (30.2) .57
<30 118 (68.6) 28 (65.1) 90 (69.8)
Genetic anomaly
Yes 20 (11.6) 6 (14.0) 14 (10.9) .58
Trisomy 21 4 (20.0) 1 (16.7) 3 (21.4)
22q11 6 (30.0) 3 (50.0) 3 (21.4) N/A
Other 10 (50.0) 2 (33.3) 8 (57.1)
Prematurity (37 wk) 14 (8.1) 4 (9.3) 10 (7.8) .75
Intraoperative
Location chest opened
OR 150 (87.2) 37 (86.1) 113 (87.6) .79
CICU 22 (12.8) 6 (14.0) 16 (12.4)
Type of surgical procedure
Single ventricle—stage I 80 (46.5) 21 (48.8) 59 (45.7) N/A
Other single ventricle 10 (5.8) 4 (9.3) 6 (4.7)
Aortic arch reconstruction 13 (7.6) 2 (4.7) 11 (8.5)
Other 2-ventricle procedure 69 (40.1) 16 (37.2) 53 (41.1)
Foreign material placed
Yes 157 (91.3) 38 (88.4) 119 (92.3) .53
No 15 (8.7) 5 (11.6) 10 (7.8)
Previous sternotomy
Yes 36 (20.9) 11 (25.6) 25 (19.4) .39
No 136 (79.1) 32 (74.4) 104 (80.6)
Cardiopulmonary bypass time (min) 124 (86-206) 120 (92-187) 128.5 (85.5-207) .80
124 86 (50.0) 21 (48.8) 65 (50.4) .83
<124 4 85 (49.4) 22 (51.2) 63 (48.8)
Missing 1 (0.6) 0 (0.0) 1 (0.8)
Aortic crossclamp time (min) 43 (35-79) 40 (30-64) 44.5 (35-82) .32
43 89 (51.7) 20 (46.5) 69 (53.5) .40
<43 82 (47.7) 23 (53.5) 59 (45.7)
Missing 1 (0.6) 0 (0.0) 1 (0.8)
Hypothermic circulatory arrest (min) 103 (59.9) 24 (55.8) 79 (61.2) .49
Data are presented as n (%) for categorical variables and median (interquartile range) for continuous variables. OR, Operating room; CICU, cardiac intensive care unit; N/A, not
applicable. *From c2 test or Fisher exact tests for categorical variables, and Wilcoxon rank sum tests for continuous variables on comparison of each characteristic between
patients with/without surgical site infections.
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Dthe discretion of the attending surgeon and is typically
based on the hemodynamic stability and coagulation status
of the patient. This institutional practice results in inclusion
of a large number of patients undergoing stage 1 palliation
who would not have otherwise required DSC based on clin-
ical status, and affects the interpretation and generalizabil-
ity of the analysis to other settings. It was impossible for us
to determine with confidence the indication for DSC in the
remainder of our subjects. This may be an important vari-
able in understanding patterns of and risk factors for SSI
in similar future cohorts.The Journal of Thoracic and CaInprevious pediatric studies, age<30days and diagnosis of
hypoplastic left heart syndrome were found to be associated
with an increased incidence of SSI in patients undergoing
DSC.6,9 Neither age nor diagnosis proved to be a risk factor
for SSI in our analysis. Age and diagnosis were likely not
identified as independent predictors of SSI due to our
institution’s use of elective DSC for all patients requiring
stage 1 palliation for single-ventricle heart disease.Onlymul-
tiple periods of DSC and need for ECMO were independent
predictors of SSI from our multivariate analysis. ECMO sup-
port in the perioperative period may elevate risk of SSI inrdiovascular Surgery c Volume 146, Number 2 329











Total periods of DSC
Once 159 (92.4) 35 (81.4) 124 (96.1) .004
More than once 13 (7.6) 8 (18.6) 5 (3.9)
Duration of initial
DSC (d)
4 (3-7) 6 (3-13) 4 (3-6) .004
<3 d 31 (18.0) 6 (14.0) 25 (19.4) .04
3-4 d 62 (36.1) 10 (23.3) 52 (40.3)
5 d 79 (45.9) 27 (62.8) 52 (40.3)
Total duration of
DSC (d)
4 (3-7.5) 9 (3-14) 4 (3-6) .0003
Total no. of mediastinal
procedures
None 97 (56.4) 15 (34.9) 82 (63.6) <.0001
1 29 (16.9) 5 (11.6) 24 (18.6)
2 27 (15.7) 11 (25.6) 16 (12.4)
3 19 (11.0) 12 (27.9) 7 (5.4)
Duration of mediastinal
chest tube (d)
7 d 75 (43.6) 13 (30.2) 62 (48.1) .001
8-14 d 73 (42.4) 16 (37.2) 57 (44.2)
>14 d 24 (14.0) 14 (32.6) 10 (7.8)
Total duration of total
parenteral
nutrition (d)
11 (6-19) 17 (8-37) 10 (5-15) .003
11 87 (50.6) 28 (65.1) 59 (45.7) .03
<11 85 (49.4) 15 (34.9) 70 (54.3)
Stress hydrocortisone
used








54 (31.4) 17 (39.5) 37 (28.7) .18




Chest 27 (15.7) 12 (27.9) 15 (11.6)
Neck 4 (2.3) 3 (7.0) 1 (0.8)
No 141 (82.0) 28 (65.1) 113 (87.6)
Data are presented as n (%) for categorical variables and median (interquartile range)
for continuous variables. DSC, Delayed sternal closure; ECMO, extracorporeal
membrane oxygenation. *From c2 test or Fisher exact tests for nominal variables,
Mantel-Haenszel tests for ordinal variables, and Wilcoxon rank sum tests for contin-
uous variables on comparison of each characteristic between patients with/without
surgical site infections. yComparison was made as ECMO Yes (ie, regardless of
cannulation site) vs No and P value was derived from c2 test.














10.5 (5.5-24.5) 15 (10-34) 9 (5-14) .004
ICU length of
stay (d)
16 (9-34.5) 29 (13-48) 15 (8-26) .004
Hospital length
of stay (d)
24 (16-47.5) 37 (18-64) 22 (16-39) .01
ICU mortality 29 (16.9) 18 (41.9) 11 (8.5) <.0001
Hospital death 30 (17.4) 19 (44.2) 11 (8.5) <.0001
Died in hospital
or within 30 d
of hospital
discharge
33 (19.2) 19 (44.2) 14 (10.9) <.0001
Data are presented as n (%) for categorical variables and median (interquartile range)
for continuous variables. ICU, Intensive care unit. *From c2 test for categorical vari-
ables and Wilcoxon rank sum tests for continuous variables on comparison of each
clinical outcome between patients with/without surgical site infections.
TABLE 4. Multivariate analysis for risk of surgical site infections
Characteristic AOR 95% CI P value*
Duration of initial DSC (d)
5 1.67 0.73, 3.85 .23
<5 Ref
Total period(s) of DSC
Once Ref .005
More than once 5.90 1.73, 20.14
ECMO 2.92 1.14, 7.60 .03
AOR, Adjusted odds ratio; CI, confidence interval; DSC, delayed sternal closure;
Ref, reference category; ECMO, extracorporeal membrane oxygenation. *From mul-
tivariate logistic regression model.
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Dnumerous ways. Systemic anticoagulation and subsequent
bleeding may require multiple explorations of the mediasti-
num. Inflammation and immunoparalysis can result from
blood–circuit interactions.15 Multiple metabolic derange-
ments, particularly hyperglycemia, are common during
ECMO support.16 Finally, extracorporeal support necessarily330 The Journal of Thoracic and Cardiovascular Surginvolves the introductionofmultiple foreign bodies to theme-
diastinum. Several general strategies could be targeted to re-
duce the risk of all infections in patients who require ECMO,
but particularly related to SSI, the care team could consider
minimizing the number ofmediastinal explorations, perform-
ing sternal closure in the operating room, or adjusting antibi-
otic prophylaxis regimens in these cases.
In the pediatric literature, the overall rate of mortality in
patients undergoing DSC varies from 12% to 36%.6,10,17 In
our study population, the overall rate of mortality in patients
requiring DSC was 19%, comparable to the recently
reported rate of 18% by Shin and colleagues.7 Higher mor-
tality rates reported in early studies were likely due to the
increased proportion of deaths occurring in patients requir-
ing mechanical circulatory support.10 In patients undergo-
ing DSC, we found that SSIs were significantly associated
with an increased risk of mortality and morbidity, including
increased hospital length of stay and prolonged duration of
mechanical ventilation.
A recent multicenter study of patients who had under-
gone stage I palliation for single-ventricle heart diseaseery c August 2013
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more frequently had higher incidences of SSI and pro-
longed length of hospital stay5 compared with centers
where it is used rarely. Studies of adult cardiac surgery pa-
tients have also found that SSI is one of the strongest predic-
tors of in-hospital mortality after DSC.18 Whether SSI is
causally related to this increase in morbidity and mortality
in patients undergoing DSC or rather merely a reflection of
greater underlying illness severity remains unclear.
We were particularly interested in the possible associa-
tion between duration of DSC and risk of SSI, hypothesiz-
ing that a longer period of DSC would increase the risk of
SSI. Multiple authors have reached variable conclusions re-
garding this question. Anderson and colleagues17 reported
that longer delay to sternal closure was associated with in-
creased risk of infection and mortality for adult patients. A
recent large, retrospective review of adult patients showed
that although prolonged delay before sternal closure was as-
sociated with poor outcome, there was no difference in the
incidence of SSI compared with patients with primary
closure.18 Previous pediatric studies have not shown an
association between duration of DSC and SSI. Although in-
creased number of days to sternal closure was associated
with increased rate of SSI on univariate analysis, it did
not remain an independent predictor of SSI in the multivari-
able analysis. Interestingly, multiple periods of DSC re-
mained independently associated with an increased risk of
SSI, suggesting that premature sternal closure resulting in
repeat DSC may place patients at higher risk of infection
than prolonging their initial period of DSC. These conclu-
sions may have important clinical implications because
many of our current CICU practices are aimed at reducing
the time to sternal closure. Due to the apparently low risk
of delaying sternal closure, CICU practices designed to
reduce the risk of requiring repeat DSC should become
a focus in the postoperative care for these patients.
We did not identify any postoperative processes indepen-
dently associated with risk of SSI. Several CICU therapies
have been shown previously to be important in modifying
the risk of SSI. Recent data suggest that protocol-based
management of glucose levels19 may reduce the risk of
SSI. The duration and choice of antibiotic prophylaxis as
well as the role of routine mediastinal cultures in the post-
operative period remains highly debated.19,20 The
relatively homogenous CICU practice patterns at our own
institution and the observational nature of our analysis no
doubt limited our ability to identify the importance of
processes of care on risk of SSI. Multi-institutional studies,
either randomized clinical trial or observational with appro-
priate statistical models to enhance causal inference, are
necessary to define the true risk factors for SSI prophylaxis
in this patient population. Results from a 2-center random-
ized clinical trial on tight glycemic control after cardiopul-
monary bypass21 may address at least 1 of these questionsThe Journal of Thoracic and Carelatively soon. However, many more potentially modifi-
able practices must be investigated in order to delineate
best practice as it relates to SSI prevention.
Limitations
This study was completed at a single center with rela-
tively homogenous intensive care unit practice patterns
and as such we had a limited opportunity to analyze the
influence of perioperative practice pattern variation on the
risk of developing SSI. The retrospective design further lim-
ited measurement of certain factors possibly related to risk
of SSI, such as decisionmaking regarding the timing of ster-
nal closure. Although thorough review of the hospital and
surgical records was completed, long-term follow-up data
for a small number of patients followed by primary cardiol-
ogists outside our center may have been incomplete.
Patients with late infections may not have been identified
and thus not included as cases. However, in our experience
most serious SSIs (eg, mediastinitis) requiring surgical con-
sultation are treated at our institution rather than at another
pediatric cardiac surgical center.
CONCLUSIONS
DSC remains an important perioperative practice for the
care of pediatric CHS patients with hemodynamic instabil-
ity and postoperative hemorrhage. The incidence of SSI in
patients undergoing DSC is significantly increased, and
SSI confers elevated risk for morbidity, mortality, and
greater resource utilization. Further multi-institution col-
laborative research is necessary to precisely identify the
specific care processes that are associated with lower infec-
tion rates and in turn implement evidenced-based strategies
for prevention of SSI in this high-risk patient population.
References
1. Jogi P, Werner O. Hemodynamic effects of sternum closure after open-heart sur-
gery in infants and children. Scand J Thorac Cardiovasc Surg. 1985;19:217-20.
2. McElhinney DB, Reddy VM, Parry AJ, Johnson L, Fineman JR, Hanley FL.
Management and outcomes of delayed sternal closure after cardiac surgery in ne-
onates and infants. Crit Care Med. 2000;28:1180-4.
3. Gangahar DM, McGough EC, Synhorst D. Secondary sternal closure: a method
of preventing cardiac compression. Ann Thorac Surg. 1981;31:281-2.
4. Das S, Rubio A, Simsic JM, Kirshbom PM, Kogon B, Kanter KR, et al. Blood-
stream infections increased after delayed sternal closure: cause or coincidence.
Ann Thorac Surg. 2011;91:793-7.
5. Johnson JN, Jaggers J, Li S, O’Brien SM, Li JS, Jacobs JP, et al. Center variation
and outcomes associated with delayed sternal closure after stage 1 palliation for
hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2010;139:1205-10.
6. Tabbutt S, Duncan BW, McLaughlin D, Wessel DL, Jonas RA, Laussen PC. De-
layed sternal closure after cardiac operations in a pediatric population. J Thorac
Cardiovasc Surg. 1997;113:886-93.
7. Shin HJ, Jhang WK, Park JJ, Yun TJ. Impact of delayed sternal closure on post-
operative infection or wound dehiscence in patients with congenital heart
disease. Ann Thorac Surg. 2011;92:705-9.
8. Sparling KW, Ryckman FC, Schoettker PJ, Byczkowski TL, Helpling A,
Mandel K, et al. Financial impact of failing to prevent surgical site infections.
Qual Manag Health Care. 2007;16:219-25.
9. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk
factors and risk adjustment for surgical site infections in pediatric cardiothoracic
surgery patients. Am J Infect Control. 2010;38:706-10.rdiovascular Surgery c Volume 146, Number 2 331
Congenital Heart Disease Harder et al
C
H
D10. Alexi-Meskishvili V, Weng Y, Uhlemann F, Lange PE, Hetzer R. Prolonged open
sternotomy after pediatric open heart operation: experience with 113 patients.
Ann Thorac Surg. 1995;59:379-83.
11. Horan TC, Andrus M, DudeckMA. CDC/NHSN surveillance definition of health
care-associated infection and criteria for specific types of infections in the acute
care setting. Am J Infect Control. 2008;36:309-32.
12. Hanauer DA, Miela G, Chinnaiyan AM, Chang AE, Blayney DW. The registry
case finding engine: an automated tool to identify cancer cases from unstructured,
free-text pathology reports and clinical notes. J Am Coll Surg. 2007;205:690-7.
13. Zampi DJ, Charpie JR, Yu S, Hanauer DA, Hirsch JC. Retrospective database re-
search in pediatric cardiology and congenital heart surgery: an illustrative example
of limitations and possible solutions.World J Pediatr Congen Heart Surg. In press.
14. Berenguer CM, Ochsner MG Jr, Lord SA, Senkowski CK. Improving surgical
site infections: using National Surgical Quality Improvement Program data to
institute Surgical Care Improvement Project protocols in improving surgical out-
comes. J Am Coll Surg. 2010;210:737-41, 41-3.
15. Cornell TT, Sun L, Hall MW, Gurney JG, Ashbrook MJ, Ohye RG, et al. Clinical
implications and molecular mechanisms of immunoparalysis after cardiopulmo-
nary bypass. J Thorac Cardiovasc Surg. 2012;143:1160-6.e1.
16. Jakob SM, Stanga Z. Perioperative metabolic changes in patients undergoing
cardiac surgery. Nutrition. 2010;26:349-53.
17. Anderson CA, Filsoufi F, Aklog L, Farivar RS, Byrne JG, Adams DH. Liberal use
of delayed sternal closure for postcardiotomy hemodynamic instability. Ann
Thorac Surg. 2002;73:1484-8.
18. Boeken U, Assmann A, Mehdiani A, Akhyari P, Lichtenberg A. Open chest man-
agement after cardiac operations: outcome and timing of delayed sternal closure.
Eur J Cardiothorac Surg. 2011;40:1146-50.
19. Woodward CS, Son M, Calhoon J, Michalek J, Husain SA. Sternal wound infec-
tions in pediatric congenital cardiac surgery: a survey of incidence and preventa-
tive practice. Ann Thorac Surg. 2011;91:799-804.
20. Maher KO, VanDerElzen K, Bove EL, Mosca RS, Chenoweth CE, Kulik TJ. A
retrospective review of three antibiotic prophylaxis regimens for pediatric car-
diac surgical patients. Ann Thorac Surg. 2002;74:1195-200.
21. Gaies MG, Langer M, Alexander J, Steil GM, Ware J, Wypij D. Design and
rationale of safe pediatric euglycemia after cardiac surgery: a randomized con-
trolled trial of tight glycemic control after pediatric cardiac surgery. Pediatr
Crit Care Med. July 12, 2012 [Epub ahead of print].APPENDIX 1. CDC/NHSN CRITERION FOR
SURGICAL SITE INFECTIONS11
Organ/Space-Organ/Space Surgical Site Infection
(SSI)
1. Infection occurs within 30 days after the operative pro-
cedure if no implant is left in place or within 1 year if im-
plant is in place and the infection appears to be related to
the operative procedure
And
2. Infection involves any part of the body, excluding the
skin incision, fascia, or muscle layers, that is opened
or manipulated during the operative procedure
And
3. Patient has at least 1 of the following:
 purulent drainage from a drain that is placed through
a stab wound into the organ/space
 organisms isolated from an aseptically obtained cul-
ture of fluid or tissue in the organ/space
 an abscess or other evidence of infection involving the
organ/space that is found on direct examination, dur-
ing reoperation, or by histopathologic or radiologic
examination332 The Journal of Thoracic and Cardiovascular Surgery diagnosis of an organ/space SSI by a surgeon or at-
tending physician.Deep Incisional Surgical Site Infection
1. Infection occurs within 30 days after the operative pro-
cedure if no implant is left in place or within 1 year if im-
plant is in place and the infection appears to be related to
the operative procedure
And
2. Involves deep soft tissues (eg, fascial and muscle layers)
of the incision
And
3. Patient has at least 1 of the following:
 purulent drainage from the deep incision but not from
the organ/space component of the surgical site
 a deep incision spontaneously dehisces or is deliber-
ately opened by a surgeon and is culture-positive or
not cultured when the patient has at least 1 of the fol-
lowing signs or symptoms: fever (>38C), or localized
pain or tenderness. A culture-negative finding does not
meet this criterion.
 an abscess or other evidence of infection involving the
deep incision is found on direct examination, during
reoperation, or by histopathologic or radiologic exam-
ination
 diagnosis of a deep incisional SSI by a surgeon or
attending physician.Superficial Incisional Surgical Site
1. Infection occurs within 30 days after the operative pro-
cedure
And
2. Involves only skin and subcutaneous tissue of the inci-
sion
And
3. Patient has at least 1 of the following:
 purulent drainage from the superficial incision
 organisms isolated from an aseptically obtained
culture of fluid or tissue from the superficial incision
 at least 1 of the following signs or symptoms of infec-
tion: pain or tenderness, localized swelling, redness,
or heat, and superficial incision is deliberately opened
by surgeon and is culture positive or not cultured. A
culture-negative finding does not meet this criterion.
 diagnosis of superficial incisional SSI by the surgeon
or attending physician.c August 2013








Ventricular septum surgery 1 (0.6) — 1 (0.8)
Atrioventricular canal surgery 3 (1.7) 2 (4.7) 1 (0.8)
Single ventricle palliation 90 (52.3) 25 (58.1) 65 (50.4)
Great vessel surgery 51 (29.7) 10 (23.3) 41 (31.8)
Left heart surgery 9 (5.2) 1 (2.3) 8 (6.2)
Right heart surgery 15 (8.7) 4 (9.3) 11 (8.5)
Chest procedures 3 (1.7) 1 (2.3) 2 (1.6)
Surgical procedure
VSD repair 1 (0.6) — 1 (0.8)
Complete atrioventricular
canal repair
3 (1.7) 2 (4.7) 1 (0.8)
BT shunt 6 (3.5) 4 (9.3) 2 (1.6)
Norwood (modified BT shunt) 57 (33.2) 10 (23.3) 47 (36.5)
Norwood (RV-PA conduit) 17 (9.9) 7 (16.3) 10 (7.8)
Bi-directional Glenn/
hemi-Fontan
2 (1.2) — 2 (1.6)
Fontan procedure 8 (4.7) 4 (9.3) 4 (3.1)
Aortic arch reconstruction 11 (6.4) 1 (2.3) 10 (7.8)
Interrupted aortic arch repair 2 (1.2) 1 (2.3) 1 (0.8)
Arterial switch operation 9 (5.2) — 9 (7.0)
Rastelli procedure 14 (8.1) 4 (9.3) 10 (7.8)
Truncus arteriosus repair 6 (3.5) 2 (4.7) 4 (3.1)
Arterial switch operation/
VSD repair
1 (0.6) 1 (2.3) —
Double-switch procedure 5 (2.9) 1 (2.3) 4 (3.1)
Other great vessel surgery 3 (1.7) — 3 (2.3)
Coronary artery surgery 1 (0.6) — 1 (0.8)
Ross procedure 1 (0.6) — 1 (0.8)
Subaortic membrane resection 1 (0.6) — 1 (0.8)
Mitral valve repair/replacement 2 (1.2) — 1 (1.6)
TAPVR repair 3 (1.7) — 3 (2.3)
Pulmonary vein stenosis
surgery
1 (0.6) 1 (2.3) —
Tetralogy of Fallot repair 7 (4.1) 2 (4.7) 5 (3.9)
Pulmonary valvotomy 1 (0.6) — 1 (0.8)
Unifocalization of pulmonary
arteries
5 (2.9) 1 (2.3) 4 (3.1)
Other right heart surgery 2 (1.2) 1 (2.3) 1 (0.8)
Cardiac tumor surgery 1 (0.6) — 1 (0.8)
Heart transplant 2 (1.2) 1 (2.3) 1 (0.8)
Data are presented as n (%). VSD, Ventricular septal defect; BT, Blalock-Taussig;
RV-PA, right ventricle to pulmonary artery; TAPVR, total anomalous pulmonary
venous return.
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